Intrinsic Value of S&P & Nasdaq Contact Us

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

Geron Corporation (GERN) has a consensus analyst rating of Buy, based on 22 analysts covering the stock. Of those, 17 recommend buying, 5 recommend holding, and 0 recommend selling.

The analyst consensus price target for GERN is $5.89, representing a +248.5% upside from the current price of $1.69. Price targets range from a low of $4.00 to a high of $8.00.

Analyst Consensus — GERN

Buy
Strong Buy
0
Buy
17
Hold
5
Sell
0
Strong Sell
0
22 analysts
Price Targets
Consensus$5.89
High$8.00
Low$4.00
Median$6.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count11
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message